Eileen Hilton, MD; Carol Singer, MD; Phyllis Kozarsky, MD; Miriam A. Smith, MD; M. Peter Lardis, BA; Michael T. Borenstein, PhD
Visitors to developing countries should be counseled and vaccinated on the basis of data about the prevalence of diseases in the areas to be visited, the traveler's level of immunity, the type of travel, and the length of stay. Little is known about the antibody status of U.S. travelers. To assess their vulnerability, we conducted a serologic survey.
From July through September 1988, travelers attending the Long Island Jewish Medical Center Travel & Immunization Center (New Hyde Park, New York) and the Travel Well Center at Crawford M. Long Hospital (Atlanta, Georgia) were asked to participate in a pretravel
Hilton E, Singer C, Kozarsky P, Smith MA, Lardis MP, Borenstein MT. Status of Immunity to Tetanus, Measles, Mumps, Rubella, and Polio among U.S. Travelers. Ann Intern Med. ;115:32–33. doi: 10.7326/0003-4819-115-1-32
Download citation file:
Published: Ann Intern Med. 1991;115(1):32-33.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use